The second wave of the coronavirus pandemic is raging in India. Hospitals are overflowing, oxygen is in short supply in some parts of the country, patients are prescribed with a number of drugs and patients' relatives are desperately looking for drugs that are also running in short in some cases. What works in the treatment for Covid-19 and what should our treating protocol be? Does plasma therapy work? Are drugs like Remdesivir useful? And what will happen if the many antibiotics taken now lead to antimicrobial resistance in the future? To speak to us about this, we have Dr. Anup Aggarwal. He is the lead author of the ICMR-led Trial on convalescent plasma (PLACID trial) and is a physician at Rehoboth McKinley Christian Hospital Healthcare Services, Gallup, New Mexico, U.S.
Hosted by Zubeda Hamid
Hosted by Zubeda Hamid
The podcast In Focus by The Hindu is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.